Majken Linnemann Jensen

Impact of a Digital Leakage Notification System on Healthcare Resource Utilisation and Costs for People with Stomas in the United Kingdom: Analysis of Interim Results from a Prospective Longitudinal Study

Alexandra Baxter, Esben Bo Boisen, Majken Linnemann Jensen, Aamir Shaikh

Background/Objectives: Leakage of stomal effluent adversely affects the quality of life for people living with a stoma and increases healthcare resource utilisation and costs. The Heylo™ digital leakage notification system (DLNS) detects early signs of leakage under the baseplate, enabling proactive stoma …

dk, gb (code pays fourni par la source)

Elevated apolipoprotein C3 heightens atherosclerosis risk by mediating arterial accumulation of free cholesterol and local inflammation in diabetes

Karin Bornfeldt, Jenny E. Kanter, Cheng-Chieh Hsu, Farah Kramer et autres

us, dk (code pays fourni par la source)

Leakage of stomal effluent outside the baseplate leads to rise in product usage and health professional interactions

Lasse de Fries Jensen, Natasha Rolls, Paul Russell-Roberts, Martin Risom Vestergaard et autres

BACKGROUND: Leakage of stomal effluent outside the baseplate that soils clothes or bedsheets is a common problem for many people with a stoma and significantly impacts their quality of life. AIM: To understand behavioural changes for people experiencing faecal leakage outside the …

dk, gb (code pays fourni par la source)

Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

Avraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, Daisuke Yabe et autres

BACKGROUND: Continued expansion of indications for sodium-glucose cotransporter-2 inhibitors increases importance of evaluating cardiovascular and kidney efficacy and safety of empagliflozin in patients with type 2 diabetes compared to similar therapies. METHODS: The EMPRISE Europe and Asia study is a non-interventional cohort …

il, de, tw, jp, kr, gb, se, fi, cn, us, dk, no, es, Égypte (code pays fourni par la source)

127-LB: Effectiveness and Safety of Empagliflozin in Routine Care in Europe and East Asia: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study

Avraham Karasik, Stefanie Lanzinger, Elise Chia-Hui Tan, Daisuke Yabe et autres

The EMPRISE study evaluates the effectiveness and safety of empagliflozin (EMPA) in a broader population of patients with T2D in routine clinical care across countries. The study included 67,140 pairs of 1:1 propensity score matched (PSM) patients ≥18 years with T2D newly …

Long-term patterns of adherence to medication therapy among patients with type 2 diabetes mellitus in Denmark: The importance of initiation

Majken Linnemann Jensen, Marit E. Jørgensen, Ebba Holme Hansen, Lise Aagaard et autres

AIMS: Poor adherence to medication therapy among type 2 diabetes patients is a clinical challenge. We aimed to determine which factors are associated with the three phases of long-term adherence to medication: initiation, implementation and discontinuation in a register-based study. METHODS: Adherence …

dk (code pays fourni par la source)

Incidence of Ketoacidosis in the Danish Type 2 Diabetes Population Before and After Introduction of Sodium–Glucose Cotransporter 2 Inhibitors—A Nationwide, Retrospective Cohort Study, 1995–2014

Majken Linnemann Jensen, Frederik Persson, Gregers S. Andersen, Martin Ridderstråle et autres

The U.S. Food and Drug Administration warns that sodium–glucose cotransporter 2 (SGLT2) inhibitors may lead to diabetic ketoacidosis (DKA). To establish a baseline occurrence of DKA in type 2 diabetes, we used national registries in Denmark to estimate incidence rates of DKA …

dk (code pays fourni par la source)

A Combined Analysis of 48 Type 2 Diabetes Genetic Risk Variants Shows No Discriminative Value to Predict Time to First Prescription of a Glucose Lowering Drug in Danish Patients with Screen Detected Type 2 Diabetes

Malene Hornbak, Kristine Højgaard Allin, Majken Linnemann Jensen, Cathrine Juel Lau et autres

OBJECTIVE: To investigate the genetic influence of 48 type 2 diabetes susceptibility variants on disease progression measured as risk of early prescription redemption of glucose lowering drugs in screen-detected patients with type 2 diabetes. METHODS: We studied type 2 diabetes progression in …

dk (code pays fourni par la source)

Improved prognosis of diabetic nephropathy in type 1 diabetes

Guðbjörg Andrésdóttir, Majken Linnemann Jensen, Bendix Carstensen, Hans‐Henrik Parving et autres

dk (code pays fourni par la source)

A Multistate Model and an Algorithm for Measuring Long-Term Adherence to Medication: A Case of Diabetes Mellitus Type 2

Majken Linnemann Jensen, Marit E. Jørgensen, Ebba Holme Hansen, Lise Aagaard et autres

dk (code pays fourni par la source)

Adherence to medication in diabetes - taking time into account

Majken Linnemann Jensen, Ebba Holme Hansen, Marit E. Jørgensen, Lise Aagaard et autres

dk, gb (code pays fourni par la source)

Type-2-diabetes patients' acceptance of long-term pharmacotherapy

Majken Linnemann Jensen, Thomas Almdal, Lise Aagaard, Marit E. Jørgensen et autres

dk, gb (code pays fourni par la source)